A recent article from The Verge discussed the latest FDA emergency approval granted to a medical device. This time it’s Fitbit’s ventilator, a low cost alternative to traditional ventilators that are in short supply as the U.S. treats COVID-19 patients. The device is called the Flow, and it will cost roughly $5,000 per unit, significantly less than other ventilators. Fitbit says the Flow isn’t meant to be a replacement for traditional ventilators, as it was designed to be used when a more expensive option isn’t available.
Quick Hits: FDA Gives Emergency Approval to Fitbit’s Ventilator
The wearable tech company developed a new ventilator to help treat the current health crisis.
Jun 9, 2020
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
